Erste Asset Management GmbH Sells 17,762 Shares of CVS Health Corporation $CVS

Erste Asset Management GmbH lessened its stake in shares of CVS Health Corporation (NYSE:CVS) by 39.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 27,343 shares of the pharmacy operator’s stock after selling 17,762 shares during the period. Erste Asset Management GmbH’s holdings in CVS Health were worth $2,066,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. SOA Wealth Advisors LLC. raised its position in CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 131 shares in the last quarter. Alteri Wealth LLC increased its stake in shares of CVS Health by 3.2% during the third quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock valued at $316,000 after buying an additional 131 shares during the period. Holistic Financial Partners raised its holdings in shares of CVS Health by 4.1% in the third quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock valued at $256,000 after acquiring an additional 133 shares in the last quarter. Symmetry Partners LLC raised its holdings in shares of CVS Health by 2.5% in the third quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after acquiring an additional 141 shares in the last quarter. Finally, Harbor Capital Advisors Inc. lifted its stake in CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares during the period. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on CVS shares. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a report on Thursday, December 4th. JPMorgan Chase & Co. boosted their price objective on shares of CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Morgan Stanley lifted their price target on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Finally, Argus reduced their price target on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Nineteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Stock Performance

CVS opened at $79.74 on Friday. The company has a market cap of $101.44 billion, a P/E ratio of 57.78, a price-to-earnings-growth ratio of 0.83 and a beta of 0.50. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The firm’s 50-day moving average price is $78.39 and its 200-day moving average price is $77.21. CVS Health Corporation has a 52-week low of $58.35 and a 52-week high of $85.15.

CVS Health (NYSE:CVS) last released its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.09. The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. CVS Health’s revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.